Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Xtandi (enzalutamide) Disease area(s): Oncology Manufacturer(s): Astellas/Pfizer 2024 Sales (USD): $7.94 billion Why it sold so well: In 2024, Astellas Pharmas Xtandi, co-marketed with Pfizer, posted strong sales growth, with revenues reaching 703.1 billion ($4.64 billion) for the first nine months (April 1, 2024 to December 31, 2024), marking a 25.6% increase compared to the same period in the previous year
To explore your options and take the next step in your journey
Their use in this context is best considered as an adjunct option for select patients
For patients on a weight-loss plan or low-carb diet, injections help maximize fat utilization during workouts and daily activity
Med., 2021, 385, 505515)
Over-the-Counter Supplements Weight loss supplements may cost $30-$100 monthly but lack FDA approval or proven efficacy, contain questionable ingredients, and rarely deliver meaningful results
US$ 26.63
US$ 29.10
US$ 22.98
US$ 20.80
US$ 29.58
US$ 23.88
US$ 27.37
US$ 21.11
